Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease

INTRODUCTION: Patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbations are at risk of further readmissions, increased treatment costs, and excess mortality. This study evaluated inpatient admissions and readmissions in patients receiving initial maintenance therapy with u...

Descripción completa

Detalles Bibliográficos
Autores principales: Slade, David, Ray, Riju, Moretz, Chad, Germain, Guillaume, Laliberté, François, Shen, Qin, Duh, Mei Sheng, MacKnight, Sean D., Hahn, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137777/
https://www.ncbi.nlm.nih.gov/pubmed/33728597
http://dx.doi.org/10.1007/s41030-021-00151-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137777/
https://www.ncbi.nlm.nih.gov/pubmed/33728597
http://dx.doi.org/10.1007/s41030-021-00151-y

Ejemplares similares